{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/mortons-neuroma/goals-outcome-measures/qipp-options-for-local-implementation/","result":{"pageContext":{"chapter":{"id":"18d2ba4f-b8d8-5c6a-98de-428afdbad5d6","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation","depth":2,"htmlHeader":"<!-- begin field 8b6b29e8-24c7-43a1-9918-4c3a51b62943 --><h2>QIPP - Options for local implementation</h2><!-- end field 8b6b29e8-24c7-43a1-9918-4c3a51b62943 -->","summary":null,"htmlStringContent":"<!-- begin item 3df3ea52-a840-4823-80cf-51bebbd27994 --><!-- begin field 471bd4ab-fbe7-4921-91d6-4e690fbf1a0a --><ul><li><strong>Nonsteroidal anti-inflammatory drugs (NSAIDs)</strong><ul><li>Review the appropriateness of NSAID prescribing widely and on a routine basis, especially in people who are at higher risk of both gastrointestinal (GI) and cardiovascular (CV) morbidity and mortality (for example, older people).</li><li>If an NSAID is needed, use ibuprofen (1200 mg per day or less) or naproxen (1000 mg per day or less). Use the lowest effective dose and the shortest duration of treatment necessary to control symptoms.</li><li>Co-prescribe a proton pump inhibitor (PPI) with NSAIDs for people with osteoarthritis, rheumatoid arthritis, or for people over 45 years with low back pain in accordance with NICE guidance.</li></ul></li></ul><p> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">NICE, 2016</a>]</p><!-- end field 471bd4ab-fbe7-4921-91d6-4e690fbf1a0a --><!-- end item 3df3ea52-a840-4823-80cf-51bebbd27994 -->","topic":{"id":"c4ebddd3-af48-5e8f-8ed1-2aa76e4070b1","topicId":"9c31e668-1581-468d-96ce-d99c2ab7aafd","topicName":"Morton's neuroma","slug":"mortons-neuroma","lastRevised":"Last revised in September 2016","chapters":[{"id":"6b4bc981-9cba-54b9-a87e-957a4ba57063","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"99c0e452-b2cc-5886-a9d5-42668ea2848b","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"e9621e25-5b00-55db-8ce0-dac8a32d6e79","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"0778b768-ea67-588d-a616-1e8395dbc885","slug":"changes","fullItemName":"Changes"},{"id":"28539e40-1bb1-5637-9513-11f21e7ec437","slug":"update","fullItemName":"Update"}]},{"id":"7b0d11fa-c26c-56a1-b4a4-06066bd88dd5","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"1bbe8a45-c581-593c-ac16-b8ee44b7ef1c","slug":"goals","fullItemName":"Goals"},{"id":"c8d77046-8667-5a33-864c-7a428a7daac5","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"84bb4d88-4dc9-5852-b1f5-dc257ef000be","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"f5e1c977-5bac-5472-819c-aa3b1384131c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"18d2ba4f-b8d8-5c6a-98de-428afdbad5d6","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b8fdf873-b643-5040-a135-509dbf09ff0a","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"f1228408-c50d-54be-8529-51d0e559cf81","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"694e194c-a565-5187-ae74-569bcc85ff8b","slug":"definition","fullItemName":"Definition"},{"id":"8a77b723-1740-585c-a700-efb1ef7e8a79","slug":"causes","fullItemName":"Causes"},{"id":"d16d1ed5-142d-55fe-8b6e-5a521a8d9949","slug":"prevalence","fullItemName":"Prevalence"},{"id":"89e18e15-c3b9-50c6-9103-876d17ded2e7","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"bcc77666-f42a-5651-9873-2e5b444c221f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"bcd4e399-0634-5e58-a78e-879494ccc88e","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"bae0d061-1470-55a9-a62b-af3e748e9746","slug":"investigations","fullItemName":"Investigations"},{"id":"eda5d38f-0ac3-58e9-8451-e66d6c910ef6","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"d564918d-68a3-50a7-852a-b99cca2bfd1e","fullItemName":"Management","slug":"management","subChapters":[{"id":"71b7c020-9e00-52e0-89f8-7dad624cea7a","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"3150c7ca-a619-5595-ab2a-0c6f1e29223d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"08c23e8c-75ad-5216-88b9-844bd1219048","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"88366459-46a4-5069-990a-87594f4f055a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"da35da28-44e3-5b98-ad77-55a820f87c55","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"a4598807-62a8-5379-a81d-f17dee67d032","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"6cabbcb4-2be8-54ac-94dd-60a42359c721","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"731a622f-9c34-59de-b09c-49032e2e130b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"6768375b-6e33-5079-bbab-ee2de85785b9","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"7b0d11fa-c26c-56a1-b4a4-06066bd88dd5","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}